These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36692908)

  • 1. Copay assistance use and prescription abandonment across race, ethnicity, or household income levels for select rheumatoid arthritis and oral oncolytic medicines.
    Wong WB; Donahue A; Thiesen J; Yeaw J
    J Manag Care Spec Pharm; 2023 Mar; 29(3):324-334. PubMed ID: 36692908
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
    Ingham M; Sadik K; Zhao X; Song J; Fendrick AM
    J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.
    Lamprea-Montealegre JA; Madden E; Tummalapalli SL; Peralta C; Neilands TB; Garcia PK; Muiru A; Karliner L; Shlipak MG; Estrella MM
    JAMA; 2022 Sep; 328(9):861-871. PubMed ID: 36066519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States.
    Nathan AS; Geng Z; Dayoub EJ; Khatana SAM; Eberly LA; Kobayashi T; Pugliese SC; Adusumalli S; Giri J; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e005600. PubMed ID: 30950652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors.
    Seetasith A; Wong W; Tse J; Burudpakdee C
    J Med Econ; 2019 May; 22(5):414-420. PubMed ID: 30729850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Differences in Cardiac Rehabilitation Participation: Effect Modification by Household Income.
    Garfein J; Guhl EN; Swabe G; Sekikawa A; Barinas-Mitchell E; Forman DE; Magnani JW
    J Am Heart Assoc; 2022 Jul; 11(13):e025591. PubMed ID: 35730601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public Benefit Programs and Differential Associations With Child Maltreatment by Race and Ethnicity.
    Puls HT; Hall M; Boyd R; Chung PJ
    JAMA Pediatr; 2024 Feb; 178(2):185-192. PubMed ID: 38109092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring disparities across the distribution of mental health care expenditures.
    Le Cook B; Manning W; Alegria M
    J Ment Health Policy Econ; 2013 Mar; 16(1):3-12. PubMed ID: 23676411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perspectives and use of copayment assistance during the COVID-19 pandemic.
    Wong WB; Jinnett K
    J Manag Care Spec Pharm; 2023 Jan; 29(1):17-23. PubMed ID: 35481416
    [No Abstract]   [Full Text] [Related]  

  • 10. Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients.
    Heun-Johnson H; Menchine M; Axeen S; Lung K; Claudius I; Wright T; Seabury SA
    JAMA Psychiatry; 2021 Mar; 78(3):311-319. PubMed ID: 33355626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial inequities in U.S. naloxone prescriptions.
    Madden EF; Qeadan F
    Subst Abus; 2020; 41(2):232-244. PubMed ID: 31718487
    [No Abstract]   [Full Text] [Related]  

  • 12. Telehealth Usage Among Low-Income Racial and Ethnic Minority Populations During the COVID-19 Pandemic: Retrospective Observational Study.
    Williams C; Shang D
    J Med Internet Res; 2023 May; 25():e43604. PubMed ID: 37171848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking race/ethnicity, income, and childhood asthma: racial/ethnic disparities concentrated among the very poor.
    Smith LA; Hatcher-Ross JL; Wertheimer R; Kahn RS
    Public Health Rep; 2005; 120(2):109-16. PubMed ID: 15842111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions.
    Streeter SB; Schwartzberg L; Husain N; Johnsrud M
    Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP38-44. PubMed ID: 21711076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program.
    Delavar A; Radha Saseendrakumar B; Weinreb RN; Baxter SL
    JAMA Ophthalmol; 2022 Apr; 140(4):354-361. PubMed ID: 35238904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.
    Biggers A; Shi Y; Charlson J; Smith EC; Smallwood AJ; Nattinger AB; Laud PW; Neuner JM
    J Clin Oncol; 2016 Dec; 34(36):4398-4404. PubMed ID: 27998232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease.
    Price JT; Zimmerman LD; Koelper NC; Sammel MD; Lee S; Butts SF
    Am J Obstet Gynecol; 2017 Nov; 217(5):572.e1-572.e10. PubMed ID: 28784416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation.
    Eberly LA; Garg L; Yang L; Markman TM; Nathan AS; Eneanya ND; Dixit S; Marchlinski FE; Groeneveld PW; Frankel DS
    JAMA Netw Open; 2021 Feb; 4(2):e210247. PubMed ID: 33635328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.
    Gellad WF; Haas JS; Safran DG
    J Gen Intern Med; 2007 Nov; 22(11):1572-8. PubMed ID: 17882499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions.
    Streeter SB; Schwartzberg L; Husain N; Johnsrud M
    J Oncol Pract; 2011 May; 7(3 Suppl):46s-51s. PubMed ID: 21886519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.